ClinicalTrials.Veeva

Menu

The Role of Probiotics in Preventing Recurrent Urinary Tract Infections in Pregnant Women

F

Frontier Medical and Dental College, Abbotabad

Status

Completed

Conditions

Urinary Tract Infections

Treatments

Other: Control Group
Dietary Supplement: Lactobacillus rhamnosus

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Urinary tract infections (UTIs) are a significant public health problem affecting more than 150 million people worldwide and causing a significant economic impact of approximately US$ 6 billion annually. It is one of the most common infectious diseases after upper respiratory tract infections. More than 50% of women and at least 12% of men will be affected by urinary tract infections in their lifetime. The probiotic supplement was delivered as easy-to-swallow capsules specifically prepared to maintain the viability and stability of the Lactobacillus rhamnosus GG strain throughout the research period. Participants were told to take the probiotic supplement with water to maximise absorption and efficiency, ideally after meals.

Enrollment

30 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women aged 18-40 year
  • History of recurrent urinary tract infections (two or more episodes in the past year).
  • Singleton pregnancy.

Exclusion criteria

  • Multiple gestations.
  • History of preterm labor.
  • Chronic medical conditions (e.g., diabetes mellitus, immunodeficiency disorders).
  • Use of antibiotics or probiotics within the past month.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Probiotic Group
Experimental group
Description:
The probiotic group received a daily oral supplement with Lactobacillus rhamnosus. The probiotic supplement was delivered as easy-to-swallow capsules.
Treatment:
Dietary Supplement: Lactobacillus rhamnosus
Control Group
Other group
Treatment:
Other: Control Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems